Does spironolactone lower my risk of heart problems if I have a large heart?
If you have heart failure with preserved ejection fraction (HFpEF) and a large heart (increased left ventricular mass or left atrial volume), spironolactone may help lower your risk of heart problems. A large heart is a sign that your heart is working harder and may be at higher risk for complications. Spironolactone is a type of medication called a mineralocorticoid receptor antagonist (MRA) that blocks the effects of aldosterone, a hormone that can cause salt and water retention and heart muscle scarring. Research suggests that spironolactone is especially beneficial for people with HFpEF who have an enlarged heart.
What the research says
A post-hoc analysis of the TOPCAT trial, which looked at spironolactone in HFpEF patients, found that the medication reduced the risk of heart problems specifically in those with a larger heart 6. In patients with increased left ventricular mass index (a measure of heart size), spironolactone lowered the risk of heart failure hospitalization by about 49% and reduced the combined risk of cardiovascular death, heart failure hospitalization, and sudden death by about 37% 6. In patients with increased left atrial volume index (another sign of heart enlargement), spironolactone reduced cardiovascular death by about 52% 6. These benefits were not seen in patients without heart enlargement, suggesting that heart size helps identify who will respond best to spironolactone 6. A network meta-analysis of multiple HFpEF treatments also found that MRAs like spironolactone reduced the composite outcome of cardiovascular death and heart failure hospitalization, though the effect was modest compared to newer drugs like SGLT2 inhibitors and GLP-1 receptor agonists 8. It is important to note that spironolactone can increase the risk of high potassium levels (hyperkalemia) and breast tenderness or enlargement (gynecomastia), so your doctor will need to monitor you closely 1.
What to ask your doctor
- Based on my heart size (left ventricular mass or left atrial volume), could spironolactone help reduce my risk of heart failure hospitalization or death?
- What are the potential side effects of spironolactone, such as high potassium or breast tenderness, and how would we monitor for them?
- Are there other medications, like SGLT2 inhibitors or GLP-1 receptor agonists, that might also be appropriate for my HFpEF?
- How often should I have blood tests to check my potassium and kidney function if I start spironolactone?
- Should I limit foods high in potassium (like bananas, oranges, or potatoes) while taking spironolactone?
This question is drawn from common patient questions about Cardiology and answered using cited medical research. We do not provide individualized advice.